The IGC announcement explicitly states it is in relation to the acquisition of the 15% interest by NKP. This statement alone means NKP should be in a halt IMHO.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
